Durable response of therapy-related MDS/AML with concomitant Waldenstr?m's macroglobulinemia treated with venetoclax and azacitidine.
Durable response of therapy-related MDS/AML with concomitant Waldenstr?m's macroglobulinemia treated with venetoclax and azacitidine. Ann Hematol. 2022 07; 101(7):1587-1589.